
loading
|
Other customers were also interested in
|
loading
|
loading
|
loading
|
A cell-permeable and reversible benzimidazolo compound that acts as a potent and ATP-competitive inhibitor of Chk2 with an IC
50 of 15 nM and a K
i of 37 nM. Displays ~ 1,000-fold greater selectivity over Cdk1/B and CK1 (IC
50 = 12 µM and 17 µM, respectively) and only weakly affects the activities of a panel of 31 kinases (< 25% inhibition at 10 µM), including Chk1. Shown to rescue both peripheral CD4
+ and CD8
+ T-cells from γ-irradiation-induced apoptosis with an EC
50 of 3 µM and 7.6 µM, respectively. Also available as a 25 mM solution in DMSO (Cat. No.
220491).
| Accessories for Chk2 Inhibitor II |
|
Product information
|
|
Form
|
Pale yellow solid
|
|
Primary Target
|
Chk2
|
|
Primary Target IC50
|
15 nM
|
|
Primary Target Ki
|
37 nM
|
|
Secondary target
|
Cdk1/B and CK1 (IC50 = 12 µM and 17 µM, respectively)
|
|
Molar mass
|
363.8
|
|
Protect from Light
|
Yes
|
|
Packaged under inert gas
|
Yes
|
|
Cell permeable
|
Yes
|
|
ATP Competitive
|
Yes
|
|
Purity
|
≥95% by HPLC
|
|
Solubility
|
DMSO
|
|
Chemical formula
|
C20H14ClN3O2
|
|
CAS number
|
516480-79-8
|
|
Store and ship information
|
|
|
|
Storage
|
+2°C to +8°C
|
|
Ship
|
Ambient Temperature Only
Standard Handling
|